Global Biologics Drug Discovery Market Size, Status and Forecast 2020-2026
- Report Code : SMA1887298
- Published On: Jul, 2020
- Category : Healthcare & Pharma
- Pages : 132
-
The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics Drug Discovery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologics Drug Discovery industry.
Based on our recent survey, we have several different scenarios about the Biologics Drug Discovery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologics Drug Discovery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Drug Discovery market in terms of revenue.
Players, stakeholders, and other participants in the global Biologics Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologics Drug Discovery market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologics Drug Discovery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Drug Discovery market.
The following players are covered in this report:
GenScript
Roche
Pfizer
Novartis
Sanofi
Merck
GlaxoSmithKline
AstraZeneca
AbbVie
Amgen
Bristol-Myers Squibb
Novo Nordisk
Allergan
Astellas Pharma
Teva Pharmaceutical Industries
Biologics Drug Discovery Breakdown Data by Type
Biologicals
Monoclonal Antibodies
Recombinant Proteins
Other Biologics
Biologics Drug Discovery Breakdown Data by Application
Hospitals
Clinics
Research Labs
Diagnostic Centers
Others
-
With tables and figures helping analyze worldwide Global Biologics Drug Discovery market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Drug Discovery Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologicals
1.4.3 Monoclonal Antibodies
1.4.4 Recombinant Proteins
1.4.5 Other Biologics1.5 Market by Application
1.5.1 Global Biologics Drug Discovery Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Labs
1.5.5 Diagnostic Centers
1.5.6 Others1.6 Coronavirus Disease 2019 (Covid-19): Biologics Drug Discovery Industry Impact
1.6.1 How the Covid-19 is Affecting the Biologics Drug Discovery Industry
1.6.1.1 Biologics Drug Discovery Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biologics Drug Discovery Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biologics Drug Discovery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions2.1 Biologics Drug Discovery Market Perspective (2015-2026)
2.2 Biologics Drug Discovery Growth Trends by Regions
2.2.1 Biologics Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biologics Drug Discovery Historic Market Share by Regions (2015-2020)
2.2.3 Biologics Drug Discovery Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biologics Drug Discovery Market Growth Strategy
2.3.6 Primary Interviews with Key Biologics Drug Discovery Players (Opinion Leaders)
3 Competition Landscape by Key Players3.1 Global Top Biologics Drug Discovery Players by Market Size
3.1.1 Global Top Biologics Drug Discovery Players by Revenue (2015-2020)
3.1.2 Global Biologics Drug Discovery Revenue Market Share by Players (2015-2020)
3.1.3 Global Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Biologics Drug Discovery Market Concentration Ratio
3.2.1 Global Biologics Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biologics Drug Discovery Revenue in 20193.3 Biologics Drug Discovery Key Players Head office and Area Served
3.4 Key Players Biologics Drug Discovery Product Solution and Service
3.5 Date of Enter into Biologics Drug Discovery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)4.1 Global Biologics Drug Discovery Historic Market Size by Type (2015-2020)
4.2 Global Biologics Drug Discovery Forecasted Market Size by Type (2021-2026)
5 Biologics Drug Discovery Breakdown Data by Application (2015-2026)5.1 Global Biologics Drug Discovery Market Size by Application (2015-2020)
5.2 Global Biologics Drug Discovery Forecasted Market Size by Application (2021-2026)
6 North America6.1 North America Biologics Drug Discovery Market Size (2015-2020)
6.2 Biologics Drug Discovery Key Players in North America (2019-2020)
6.3 North America Biologics Drug Discovery Market Size by Type (2015-2020)
6.4 North America Biologics Drug Discovery Market Size by Application (2015-2020)
7 Europe7.1 Europe Biologics Drug Discovery Market Size (2015-2020)
7.2 Biologics Drug Discovery Key Players in Europe (2019-2020)
7.3 Europe Biologics Drug Discovery Market Size by Type (2015-2020)
7.4 Europe Biologics Drug Discovery Market Size by Application (2015-2020)
8 China8.1 China Biologics Drug Discovery Market Size (2015-2020)
8.2 Biologics Drug Discovery Key Players in China (2019-2020)
8.3 China Biologics Drug Discovery Market Size by Type (2015-2020)
8.4 China Biologics Drug Discovery Market Size by Application (2015-2020)
9 Japan9.1 Japan Biologics Drug Discovery Market Size (2015-2020)
9.2 Biologics Drug Discovery Key Players in Japan (2019-2020)
9.3 Japan Biologics Drug Discovery Market Size by Type (2015-2020)
9.4 Japan Biologics Drug Discovery Market Size by Application (2015-2020)
10 Southeast Asia10.1 Southeast Asia Biologics Drug Discovery Market Size (2015-2020)
10.2 Biologics Drug Discovery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biologics Drug Discovery Market Size by Type (2015-2020)
10.4 Southeast Asia Biologics Drug Discovery Market Size by Application (2015-2020)
11 India11.1 India Biologics Drug Discovery Market Size (2015-2020)
11.2 Biologics Drug Discovery Key Players in India (2019-2020)
11.3 India Biologics Drug Discovery Market Size by Type (2015-2020)
11.4 India Biologics Drug Discovery Market Size by Application (2015-2020)
12 Central & South America12.1 Central & South America Biologics Drug Discovery Market Size (2015-2020)
12.2 Biologics Drug Discovery Key Players in Central & South America (2019-2020)
12.3 Central & South America Biologics Drug Discovery Market Size by Type (2015-2020)
12.4 Central & South America Biologics Drug Discovery Market Size by Application (2015-2020)
13 Key Players Profiles13.1 GenScript
13.1.1 GenScript Company Details
13.1.2 GenScript Business Overview and Its Total Revenue
13.1.3 GenScript Biologics Drug Discovery Introduction
13.1.4 GenScript Revenue in Biologics Drug Discovery Business (2015-2020))
13.1.5 GenScript Recent Development13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview and Its Total Revenue
13.2.3 Roche Biologics Drug Discovery Introduction
13.2.4 Roche Revenue in Biologics Drug Discovery Business (2015-2020)
13.2.5 Roche Recent Development13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Biologics Drug Discovery Introduction
13.3.4 Pfizer Revenue in Biologics Drug Discovery Business (2015-2020)
13.3.5 Pfizer Recent Development13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Biologics Drug Discovery Introduction
13.4.4 Novartis Revenue in Biologics Drug Discovery Business (2015-2020)
13.4.5 Novartis Recent Development13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview and Its Total Revenue
13.5.3 Sanofi Biologics Drug Discovery Introduction
13.5.4 Sanofi Revenue in Biologics Drug Discovery Business (2015-2020)
13.5.5 Sanofi Recent Development13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview and Its Total Revenue
13.6.3 Merck Biologics Drug Discovery Introduction
13.6.4 Merck Revenue in Biologics Drug Discovery Business (2015-2020)
13.6.5 Merck Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.7.3 GlaxoSmithKline Biologics Drug Discovery Introduction
13.7.4 GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview and Its Total Revenue
13.8.3 AstraZeneca Biologics Drug Discovery Introduction
13.8.4 AstraZeneca Revenue in Biologics Drug Discovery Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 AbbVie
13.9.1 AbbVie Company Details
13.9.2 AbbVie Business Overview and Its Total Revenue
13.9.3 AbbVie Biologics Drug Discovery Introduction
13.9.4 AbbVie Revenue in Biologics Drug Discovery Business (2015-2020)
13.9.5 AbbVie Recent Development13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview and Its Total Revenue
13.10.3 Amgen Biologics Drug Discovery Introduction
13.10.4 Amgen Revenue in Biologics Drug Discovery Business (2015-2020)
13.10.5 Amgen Recent Development
13.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Details
10.11.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
10.11.3 Bristol-Myers Squibb Biologics Drug Discovery Introduction
10.11.4 Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2015-2020)
10.11.5 Bristol-Myers Squibb Recent Development
13.12 Novo Nordisk
10.12.1 Novo Nordisk Company Details
10.12.2 Novo Nordisk Business Overview and Its Total Revenue
10.12.3 Novo Nordisk Biologics Drug Discovery Introduction
10.12.4 Novo Nordisk Revenue in Biologics Drug Discovery Business (2015-2020)
10.12.5 Novo Nordisk Recent Development
13.13 Allergan
10.13.1 Allergan Company Details
10.13.2 Allergan Business Overview and Its Total Revenue
10.13.3 Allergan Biologics Drug Discovery Introduction
10.13.4 Allergan Revenue in Biologics Drug Discovery Business (2015-2020)
10.13.5 Allergan Recent Development
13.14 Astellas Pharma
10.14.1 Astellas Pharma Company Details
10.14.2 Astellas Pharma Business Overview and Its Total Revenue
10.14.3 Astellas Pharma Biologics Drug Discovery Introduction
10.14.4 Astellas Pharma Revenue in Biologics Drug Discovery Business (2015-2020)
10.14.5 Astellas Pharma Recent Development
13.15 Teva Pharmaceutical Industries
10.15.1 Teva Pharmaceutical Industries Company Details
10.15.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
10.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Introduction
10.15.4 Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2015-2020)
10.15.5 Teva Pharmaceutical Industries Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Biologics Drug Discovery Key Market Segments
Table 2. Key Players Covered: Ranking by Biologics Drug Discovery Revenue
Table 3. Ranking of Global Top Biologics Drug Discovery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biologics Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologicals
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Recombinant Proteins
Table 8. Key Players of Other Biologics
Table 9. COVID-19 Impact Global Market: (Four Biologics Drug Discovery Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Biologics Drug Discovery Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Biologics Drug Discovery Players to Combat Covid-19 Impact
Table 14. Global Biologics Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Biologics Drug Discovery Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Biologics Drug Discovery Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Biologics Drug Discovery Market Share by Regions (2015-2020)
Table 18. Global Biologics Drug Discovery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Biologics Drug Discovery Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Biologics Drug Discovery Market Growth Strategy
Table 24. Main Points Interviewed from Key Biologics Drug Discovery Players
Table 25. Global Biologics Drug Discovery Revenue by Players (2015-2020) (Million US$)
Table 26. Global Biologics Drug Discovery Market Share by Players (2015-2020)
Table 27. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Discovery as of 2019)
Table 28. Global Biologics Drug Discovery by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Biologics Drug Discovery Product Solution and Service
Table 31. Date of Enter into Biologics Drug Discovery Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 34. Global Biologics Drug Discovery Market Size Share by Type (2015-2020)
Table 35. Global Biologics Drug Discovery Revenue Market Share by Type (2021-2026)
Table 36. Global Biologics Drug Discovery Market Size Share by Application (2015-2020)
Table 37. Global Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 38. Global Biologics Drug Discovery Market Size Share by Application (2021-2026)
Table 39. North America Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 41. North America Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 42. North America Biologics Drug Discovery Market Share by Type (2015-2020)
Table 43. North America Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 44. North America Biologics Drug Discovery Market Share by Application (2015-2020)
Table 45. Europe Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 47. Europe Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Biologics Drug Discovery Market Share by Type (2015-2020)
Table 49. Europe Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Biologics Drug Discovery Market Share by Application (2015-2020)
Table 51. China Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 52. China Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 53. China Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 54. China Biologics Drug Discovery Market Share by Type (2015-2020)
Table 55. China Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 56. China Biologics Drug Discovery Market Share by Application (2015-2020)
Table 57. Japan Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 59. Japan Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Biologics Drug Discovery Market Share by Type (2015-2020)
Table 61. Japan Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Biologics Drug Discovery Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 65. Southeast Asia Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Biologics Drug Discovery Market Share by Type (2015-2020)
Table 67. Southeast Asia Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Biologics Drug Discovery Market Share by Application (2015-2020)
Table 69. India Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 70. India Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 71. India Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 72. India Biologics Drug Discovery Market Share by Type (2015-2020)
Table 73. India Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 74. India Biologics Drug Discovery Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Biologics Drug Discovery Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Biologics Drug Discovery Market Share (2019-2020)
Table 77. Central & South America Biologics Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Biologics Drug Discovery Market Share by Type (2015-2020)
Table 79. Central & South America Biologics Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Biologics Drug Discovery Market Share by Application (2015-2020)
Table 81. GenScript Company Details
Table 82. GenScript Business Overview
Table 83. GenScript Product
Table 84. GenScript Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 85. GenScript Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Product
Table 109. Merck Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 110. Merck Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Product
Table 114. GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 115. GlaxoSmithKline Recent Development
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Product
Table 118. AstraZeneca Company Details
Table 119. AstraZeneca Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 120. AstraZeneca Recent Development
Table 121. AbbVie Company Details
Table 122. AbbVie Business Overview
Table 123. AbbVie Product
Table 124. AbbVie Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 125. AbbVie Recent Development
Table 126. Amgen Company Details
Table 127. Amgen Business Overview
Table 128. Amgen Product
Table 129. Amgen Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 130. Amgen Recent Development
Table 131. Bristol-Myers Squibb Company Details
Table 132. Bristol-Myers Squibb Business Overview
Table 133. Bristol-Myers Squibb Product
Table 134. Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 135. Bristol-Myers Squibb Recent Development
Table 136. Novo Nordisk Company Details
Table 137. Novo Nordisk Business Overview
Table 138. Novo Nordisk Product
Table 139. Novo Nordisk Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 140. Novo Nordisk Recent Development
Table 141. Allergan Company Details
Table 142. Allergan Business Overview
Table 143. Allergan Product
Table 144. Allergan Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 145. Allergan Recent Development
Table 146. Astellas Pharma Company Details
Table 147. Astellas Pharma Business Overview
Table 148. Astellas Pharma Product
Table 149. Astellas Pharma Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 150. Astellas Pharma Recent Development
Table 151. Teva Pharmaceutical Industries Company Details
Table 152. Teva Pharmaceutical Industries Business Overview
Table 153. Teva Pharmaceutical Industries Product
Table 154. Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2015-2020) (Million US$)
Table 155. Teva Pharmaceutical Industries Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Drug Discovery Market Share by Type: 2020 VS 2026
Figure 2. Biologicals Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Recombinant Proteins Features
Figure 5. Other Biologics Features
Figure 6. Global Biologics Drug Discovery Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Labs Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Biologics Drug Discovery Report Years Considered
Figure 13. Global Biologics Drug Discovery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Biologics Drug Discovery Market Share by Regions: 2020 VS 2026
Figure 15. Global Biologics Drug Discovery Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Biologics Drug Discovery Market Share by Players in 2019
Figure 18. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Discovery as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Biologics Drug Discovery Revenue in 2019
Figure 20. North America Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Biologics Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. GenScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GenScript Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sanofi Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 37. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Merck Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 39. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 43. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. AbbVie Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 45. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Amgen Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 47. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 49. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novo Nordisk Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 51. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Allergan Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 53. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Astellas Pharma Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 55. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in Biologics Drug Discovery Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
-
The Global Biologics Drug Discovery Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Global Biologics Drug Discovery has a wide range of applications, including
The Global Biologics Drug Discovery Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
In addition to the Global Biologics Drug Discovery Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Global Biologics Drug Discovery Market.
During the forecast years, the Global Biologics Drug Discovery Market can thrive with a robust CAGR.
